Dhawan V, Niethammer MH, Lesser ML, Pappas KN, Hellman M, Fitzpatrick TM, Bjelke D, Singh J, Quatarolo LM, Choi YY, Oh A, Eidelberg D, Chaly T
Purpose We present the findings of our final prospective study submitted to the U.S. Food and Drug Administration (FDA) for New Drug Application (NDA) approval for the use of 3,4-dihydroxy-6-[18F]fluoro-L-phenylalanine...